Document is current
Any future updates will be listed below
-
Authors
Yang, Xiuxiu
Xu, Qian https://orcid.org/0000-0002-3841-0174
Wang, Jue
Ye, Shanwei
Markmann, Caroline https://orcid.org/0000-0002-7219-9798
Zhang, Shujia
Zhang, Qian https://orcid.org/0000-0002-2858-0962
Bhoj, Vijay G. https://orcid.org/0000-0003-2857-4092
Huang, Liang https://orcid.org/0000-0002-8370-3232
Zhang, Zheng https://orcid.org/0000-0002-3242-5738
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82200253)
National Natural Science Foundation of China (82470194)
National Natural Science Foundation of China (82402821)
Burrough Welcome Fund – Career Award for Medicine Scientists
Penn Center for Targeted Therapeutics and Translational Nanomedicine (CT3N) Pilot Grant
National Center for Advancing Translational Sciences of the National Institutes of Health (UL1TR001878)
National Key R&D Program of China (2022YFC2502604)
CAMS Innovation Fund for Medical Sciences (2024-I2M-3-021)
- License Information
-
More Information
Article History
Received: 13 October 2025
Accepted: 19 January 2026
First Online: 7 February 2026
Declarations
:
: Z.Z. and Q.X. are inventors on a granted patent (CN116083369B) related to the CD19×CD3 BiTE EVs platform. All other authors declare no competing interests.
